Avestar Capital, LLC Amgen Inc Transaction History

Avestar Capital, LLC

$951 Million
Q3 2024

A detailed history of Avestar Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Avestar Capital, LLC holds 4,570 shares of AMGN stock, worth $1.21 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

4,570

Previous 4,226 8.14%

Holding current value

$1.21 Million

Previous $1.32 Million 11.52%

% of portfolio

0.15%

Previous 0.14%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$309.38 - $337.38 $106,426 - $116,058	344 Added 8.14%	4,570 $1.47 Million
Q2 2024 Aug 08, 2024	BUY	$262.75 - $319.31 $428,545 - $520,794	1,631 Added 62.85%	4,226 $1.32 Million
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $145,996 - $176,236	543 Added 26.46%	2,595 $737,000
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $194,332 - $219,229	760 Added 58.82%	2,052 $591,000
Q3 2023 Oct 20, 2023	BUY	$218.65 - $271.46 $282,495 - $350,726	1,292 New	1,292 $347,000
Q4 2022 Jan 20, 2023	BUY	$229.03 - $291.01 $198,798 - $252,596	868 New	868 $0
Q3 2019 Nov 14, 2019	SELL	$174.11 - $208.62 $30,817 - $36,925	-177 Closed	0 $0
Q2 2019 Aug 06, 2019	SELL	$166.7 - $195.41 $6,668 - $7,816	-40 Reduced 18.43%	177 $29,000
Q1 2019 May 09, 2019	SELL	$180.87 - $203.88 $11,937 - $13,456	-66 Reduced 23.32%	217 $37,000
Q4 2018 Jan 25, 2019	BUY	$178.4 - $208.25 $2,497 - $2,915	14 Added 5.2%	283 $51,000
Q3 2018 Oct 23, 2018	SELL	$185.29 - $208.89 $5,188 - $5,848	-28 Reduced 9.43%	269 $53,000
Q2 2018 Aug 10, 2018	BUY	$166.05 - $186.51 $1,162 - $1,305	7 Added 2.41%	297 $51,000
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $8,810 - $10,296	52 Added 21.85%	290 $46,000
Q4 2017 Feb 14, 2018	BUY	$168.79 - $188.59 $40,172 - $44,884	238	238 $39,000

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.

Account

Avestar Capital, LLC Amgen Inc Transaction History